PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 129 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $237,511 | -63.3% | 21,770 | -71.7% | 0.00% | -66.7% |
| Q3 2022 | $648,000 | +50.0% | 76,862 | +40.6% | 0.00% | +50.0% |
| Q2 2022 | $432,000 | +32.1% | 54,676 | +295.9% | 0.00% | +100.0% |
| Q1 2022 | $327,000 | -84.2% | 13,810 | -77.2% | 0.00% | -80.0% |
| Q4 2021 | $2,069,000 | +506.7% | 60,490 | +258.1% | 0.01% | +66.7% |
| Q4 2020 | $341,000 | -90.0% | 16,893 | -85.7% | 0.00% | -94.5% |
| Q2 2020 | $3,414,000 | +1203.1% | 118,120 | +218.5% | 0.06% | +685.7% |
| Q1 2020 | $262,000 | -60.1% | 37,083 | -60.2% | 0.01% | +75.0% |
| Q4 2019 | $656,000 | -35.0% | 93,103 | +10.8% | 0.00% | -55.6% |
| Q3 2019 | $1,009,000 | -18.6% | 84,034 | -17.9% | 0.01% | -25.0% |
| Q2 2019 | $1,239,000 | +120.1% | 102,337 | +128.5% | 0.01% | +100.0% |
| Q1 2019 | $563,000 | +223.6% | 44,777 | +73.5% | 0.01% | +200.0% |
| Q4 2018 | $174,000 | -53.2% | 25,804 | -28.5% | 0.00% | -50.0% |
| Q3 2018 | $372,000 | +14.1% | 36,110 | -25.5% | 0.00% | 0.0% |
| Q2 2018 | $326,000 | +129.6% | 48,467 | +193.2% | 0.00% | +100.0% |
| Q1 2018 | $142,000 | – | 16,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |